Banque Pictet & Cie’s Atea Pharmaceuticals AVIR Stock Holding History

Banque Pictet & Cie’s Portfolio AVIR Stock Details AVIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.6M	Hold	345,077	–	–	0.01%	212
2026 Q1	$1.86M	Hold	345,077	–	–	0.01%	227
2025 Q4	$1.23M	Hold	345,077	–	–	0.01%	249
2025 Q3	$1M	Hold	345,077	–	–	0.01%	265
2025 Q2	$1.24M	Hold	345,077	–	–	0.01%	237
2025 Q1	$1.03M	Hold	345,077	–	–	0.01%	249
2024 Q4	$1.16M	Hold	345,077	–	–	0.01%	241
2024 Q3	$1.16M	Hold	345,077	–	–	0.01%	222
2024 Q2	$1.14M	Hold	345,077	–	–	0.01%	221
2024 Q1	$1.39M	Hold	345,077	–	–	0.01%	214
2023 Q4	$1.05M	Hold	345,077	–	–	0.01%	234
2023 Q3	$1.04M	Hold	345,077	–	–	0.01%	272
2023 Q2	$1.29M	Hold	345,077	–	–	0.01%	294
2023 Q1	$1.16M	Hold	345,077	–	–	0.01%	356
2022 Q4	$1.66M	Hold	345,077	–	–	0.02%	318
2022 Q3	$1.96M	Hold	345,077	–	–	0.02%	290
2022 Q2	$2.45K	Hold	345,077	–	–	0.02%	272
2022 Q1	$2.49M	Buy	345,077 +56,481	+20%	+$384K	0.02%	293
2021 Q4	$2.58M	Sell	288,596 -150,000	-34%	-$2.34M	0.02%	291
2021 Q3	$15.4M	Sell	438,596 -56,481	-11%	-$1.57M	0.16%	75
2021 Q2	$10.6M	Buy	+495,077	New	+$14.9M	0.12%	90

Other funds holding AVIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Auour Investments Woburn, Massachusetts $349M AUM 13.68% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Banque Pictet & Cie's AVIR Position: Q2 2026 in Review

Banque Pictet & Cie held its Atea Pharmaceuticals (AVIR) position steady in Q2 2026 at 345,077 shares worth $1.6M. The position accounts for 0.01% of the portfolio, ranked #212.

Banque Pictet & Cie first reported a position in AVIR in Q2 2021 and has held it in 21 quarters since. The position peaked at $15.4M in Q3 2021. 48 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

Banque Pictet & Cie held 345,077 shares of Atea Pharmaceuticals worth $1.6M as of Q2 2026.
Banque Pictet & Cie left its Atea Pharmaceuticals share count unchanged in Q2 2026.
Atea Pharmaceuticals made up 0.01% of Banque Pictet & Cie's portfolio in Q2 2026, its #212 holding.
Banque Pictet & Cie first reported a position in Atea Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
Banque Pictet & Cie's Atea Pharmaceuticals position peaked at $15.4M in Q3 2021.
48 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.